News

FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply
Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern ...
Novavax lifts 2025 revenue outlook after FDA milestone payment
Novavax on Wednesday raised its full-year revenue forecast as it received a $175 million milestone payment from Sanofi ...
FDA reinstates top vaccines regulator just days after his abrupt departure
At the U.S. Food and Drug Administration's (FDA) request, Vinay Prasad is returning to the role of director of the Center for ...
BioPharma Dive2d
Vinay Prasad, in surprise reversal, to rejoin FDA after abrupt departure
Less than weeks after stepping down, Prasad will return to lead CBER “at the FDA’s request,” according to an HHS spokesperson ...
NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View
Novavax tops Q2 estimates and lifts 2025 sales forecast as Sanofi takes over global rollout of its COVID vaccine.
RFK Jr.'s FDA officials overrode career staff to limit COVID shots
The FDA's Dr. Vinay Prasad said that he disagreed with the agency's career vaccine reviewers about COVID shot approvals.
MedPage Today on MSN4d
Did FDA Pick the Wrong COVID Vaccine Strain Last Season? | MedPage Today
In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related ...
The New York Sun12d
FDA’s Top Regulator Is Out Amid MAHA Backlash Over Blocking Access to a $3.2 Million Per Dose Therapy for Rare Disorder in Boys
Vinay Prasad, who came under fire from patient advocacy groups and Laura Loomer, is gone after less than three months on the ...
ksby4y
FDA authorizes Novavax's protein-based COVID-19 vaccine
The Food and Drug Administration (FDA) signed off Wednesday on an emergency use authorization for the Novavax COVID-19 vaccine for individuals 18 years of age and older.